WELCOME TO BCBA

AUSTRALIAN BRAIN CANCER REGISTRY PLATFORM

September 2023

Our Consortium is driving a national collaboration to develop an integrated network of platforms across research, registry trials and patient care to accelerate brain cancer research.

Platform one is the Australian Brain Cancer Registry, which will systematically collect the treatment and outcome data of as many Australians living with brain cancer as possible. This will give clinicians and healthcare providers the big data they need to identify variations in patient care and ensure that brain cancer patients across Australia receive the best available treatment and care.

This is just our first step in enabling improvements in patient outcomes today, testing new treatments for tomorrow, and finding cures for the future.

Learn more about our collaboration here | bit.ly/AusBCregistry

Repurposing Existing Drugs to treat Brain Cancer

August 2023

BCBA Consortium Member, Stuart Pitson is excited by the potential of repurposing existing drugs to treat glioblastoma. The NeuroSurgical Research Foundation Professor of Brain Tumour Research at the University of South Australia has a strong focus on using fundamental biology to develop and evaluate new therapeutic approaches,

“We hope to be able to capitalise on our newly discovered knowledge of brain tumour biology, patient tumour samples and our advanced pre-clinical models to evaluate new approaches to treat glioblastoma”.

The pre-clinical models of glioblastoma Pitson developed have already contributed to the establishment of two clinical trials of new therapies.

“I will never get tired of the excitement of discovering something that has never been discovered before”.

2023 BCBA Consortium Meeting

9th October 2023

The 2023 Annual Meeting of the BCBA Consortium will be held in conjunction with the COGNO ASM in Sydney on Monday 9th October, 12.30pm – 1.30pm.